Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL1333562

CC(=O)OC(C(=O)O)C(OC(C)=O)C(=O)O.N

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.48
TP53 P04637 2/20 0.39
SLC1A3 P43003 1/20 0.39
SLC1A2 P43004 1/20 0.39
SLC1A1 P43005 1/20 0.39
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
ALOX15 P16050 1/20 0.37
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM1 P11229 1/20 0.36
TBXA2R P21731 1/20 0.36
ALDH1A1 P00352 3/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
GALR3 O60755 1/20 0.34
MAPT P10636 1/20 0.34
BLM P54132 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1442538 0.97 TSHR (0.50) TSHRTP53SLC1A3SLC1A2SLC1A1
SCHEMBL13849512 0.97 TSHR (0.50) TSHRTP53SLC1A3SLC1A2SLC1A1
SCHEMBL42203 0.97 TSHR (0.50) TSHRTP53SLC1A3SLC1A2SLC1A1
SCHEMBL7092944 0.97 TSHR (0.50) TSHRTP53SLC1A3SLC1A2SLC1A1
SCHEMBL255602 0.97 TSHR (0.50) TSHRTP53SLC1A3SLC1A2SLC1A1
Hydrochloric Acid SCHEMBL9842020 0.94 TSHR (0.48) TSHRTP53SLC1A3SLC1A2SLC1A1
Water SCHEMBL28115835 0.94 TSHR (0.48) TSHRTP53SLC1A3SLC1A2SLC1A1
SCHEMBL18857848 0.89 TSHR (0.43) TSHRTP53SLC1A3SLC1A2SLC1A1
SCHEMBL28297278 0.89 TSHR (0.43) TSHRTP53SLC1A3SLC1A2SLC1A1
SCHEMBL8458943 0.85 TSHR (0.40) TSHRTP53SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102971335-A Reversibly terminating primer extension reagents BENNER STEVEN ALBERT 2013-03-13 CN disclosed
US-8212020-B2 Reagents for reversibly terminating primer extension BENNER STEVEN ALBERT (US) 2012-07-03 US disclosed
US-20110275124-A1 Reagents for reversibly terminating primer extension BENNER STEVEN A 2011-11-10 US disclosed
WO-2010110775-A1 REAGENTS FOR REVERSIBLY TERMINATING PRIMER EXTENSION BENNER STEVEN ALBERT (US) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275124-A1 Reagents for reversibly terminating primer extension RNGTT, POLRMT, DNTT TSHR 672/4885TP53 764/4885SLC1A3 4475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.